Brainstorm settles specific derivative litigation
Brainstorm Cell Therapeutics Inc. filed notice regarding a proposed settlement of a stockholder derivative action and the dismissal of a separate Section 220 inspection demand in New York federal court.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed